In a nutshell, Review
A new role for the nuclear basket network
Paola Gallardo1, Silvia Salas-Pino1 and Rafael R. Daga1
This article comments on work published by Salas-Pino et al. (J Cell Biol, 2017), which describes a novel function of the fission yeast nuclear basket component - the translocated promoter region (TPR) nucleoporin Alm1 - in proper localization of the proteasome to the nuclear envelope.
VAMP8 mucin exocytosis attenuates intestinal pathogenesis by Entamoeba histolytica
Steve Cornick1, France Moreau1, Herbert Y. Gaisano2, Kris Chadee1
This article comments on work published by Cornick et al. (mBio, 2017), which nominates SNARE-mediated exocytosis as the putative mechanism responsible for pathogen-induced mucus secretion from goblet cells.
Shutdown of interferon signaling by a viral-hijacked E3 ubiquitin ligase
Kaitlin A. Davis1 and John T. Patton2
This article comments on work published by Davis et al. (mBio, 2017), which describes molecular requirements that govern NSP1 recognition of β-TrCP, including an essential degron phosphorylation event, and the step-wise incorporation of NSP1 into hijacked cullin-RING E3 ligases (CRLs) that ubiquitinate and tag β-TrCP for degradation.
Breaking the bad: Bacillus blocks fungal virulence factors
François L. Mayer1 and James W. Kronstad1
This article comments on work published by Mayer & Kronstad (mBio, 2017), which identified the soil bacterium, Bacillus safensis as a potent inhibitor of virulence factor production by two major fungal pathogens of humans, Cryptococcus neoformans, and Candida albicans.
The integrated stress response in budding yeast lifespan extension
Spike D.L. Postnikoff1, Jay E. Johnson2 and Jessica K. Tyler1
This article summarizes how the budding yeast Saccharomyces cerevisiae has been instrumental in unraveling the molecular and cellular determinants of aging, and how the induction of cellular stress responses has been associated with experimental lifespan extension, thus underscoring the value of yeast as a model for developing potential aging therapies for humans.
Macrophages as drivers of an opportunistic infection
Annette C. Vergunst1, Nazareth Lopez Carranza1, Lili Zhang1,2, Margarida C. Gomes1, Yara Tasrini1,
Annemarie H. Meijer3 and David O’Callaghan1
This article comments on work published by Mesureur et al. (PloS Pathog, 2017), which shows that macrophages are essential for proliferation of B. cenocepacia in the host. This suggests a new paradigm for Bcc infections and urges the development of novel anti-infectious therapies to efficiently disarm these intrinsically antibiotic resistant facultative intracellular pathogens.
Exacerbating and reversing lysosomal storage diseases: from yeast to humans
Tamayanthi Rajakumar1, Andrew B. Munkacsi1,2 and Stephen L. Sturley3
This article summarizes the use of yeast models in advancing our understanding of lysosomal storage diseases (LSDs), where they have been instrumental in researching LSD mechanisms, screening for therapeutic compounds, and exploring genetic and gene-environment interactions relevant to diseases like Batten disease, cystinosis, and Niemann-Pick type C disease, as well as their connection to broader health issues such as viral infections and obesity.
Paving the way for new antimicrobial peptides through molecular de-extinction
February 20, 2025
The advancement of artificial intelligence and molecular de-extinction offers a valuable opportunity not only to discover new antimicrobials but also to provide accurate in silico predictions, thereby shortening the path to addressing the global antibiotic resistance crisis.
Efflux pumps: gatekeepers of antibiotic resistance in Staphylococcus aureus biofilms
November 11, 2024
This review aims to elucidate the complex relationship between efflux pumps, antibiotic resistance and biofilm formation in S. aureus with the aim to aid in the development of potential therapeutic targets for combating S. aureus infections, especially those associated with biofilms.
Understanding the molecular mechanisms of human diseases: the benefits of fission yeasts
August 2, 2024
Here we collect the latest laboratory protocols and bioinformatics tools for the fission yeasts to highlight the many possibilities available to the research community. In addition, we present several limiting factors that everyone should be aware of when working with yeast models.
Characterising glycosaminoglycans in human breastmilk and their potential role in infant health
July 4, 2024
Glycosaminoglycans are bioactive components present in breast milk and play a potential key role in determining infant health yet are overlooked by many contemporary studies. This review explores their relevance, use and characterisation techniques.
From microbes to medicine: harnessing the gut microbiota to combat prostate cancer
May 23, 2024
The gut microbiome (GM) has been identified as a crucial factor in the development and progression of various diseases, including cancer. This review highlights the important role that the GM may play in the development and progression of prostate cancer, through its influence on chronic inflammation, immune modulation, and other pathogenic mechanisms.
The cAMP-PKA signalling crosstalks with CWI and HOG-MAPK pathways in yeast cell response to osmotic and thermal stress
March 15, 2024
During industrial fermentation yeast strains are exposed to fluctuations in oxygen concentration, osmotic pressure, pH, ethanol concentration, nutrient availability and temperature. The scope of this review is to outline the advancement of knowledge about the cAMP-PKA signalling and the crosstalk of this pathway with the CWI and HOG-MAPK cascades in response to the environmental challenges heat and hyperosmotic stress.
Biofilm tolerance, resistance and infections increasing threat of public health
September 26, 2023
The review explores the role of biofilms in the development of bacterial resistance mechanisms and proposed therapeutic intervention strategies for biofilm related diseases.
Infinity war: Trichomonas vaginalis and interactions with host immune response
March 31, 2023
Trichomonas vaginalis is the pathological agent of human trichomoniasis with an incidence of 156 million cases worldwide. This review highlights parasite strategies to activate and stimulate or evade variated and complex immunological mechanisms related to the symptoms and clinical complications observed here.